bibliographic resource 1535566 [br/1535566]
https://w3id.org/oc/corpus/br/1535566
- is a
-
- title
-
- Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations
- publication date
-
- contributor
-
- identifier
-
- part of
-